Scholarlink

Background <p>Beta-amyloid (Aβ) plaques and tau tangles are pathological hallmarks of Alzheimer’s disease (AD); however, autopsy studies reveal that most older adults also present with cerebrovascular disease (CVD) markers. It remains unclear how Aβ and tau relate to cognition in the context of concurrent CVD. In initially cognitively unimpaired older adults with CVD, this study aimed to determine <i>ante-mortem</i> cognitive trajectories associated with elevated Aβ and/or tau at autopsy.</p> Methods <p>Participants aged 65–95 classified as cognitively unimpaired at baseline from the National Alzheimer’s Coordinating Center database, with ≥ 1 follow-up between 2005 and 2015, and available autopsy/<i>APOE</i> data were included in this cohort study (<i>N</i> = 863). All participants had at least one of six CVD markers at autopsy. Participants were classified into four groups (A − T−, A + T−, A − T+, A + T+) based on semiquantitative Consortium to Establish a Registry for Alzheimer’s Disease neuritic plaque staging and Braak staging. Linear mixed models assessed rate of change in Preclinical Alzheimer’s Cognitive Composite scores, episodic memory, and executive function.</p> Results <p>A + T + adults demonstrated significantly faster cognitive decline on all outcomes in the ~ 10 years preceding death compared to A − T− adults (d = 0.34–0.46). Similarly, when compared to A + T − adults, A + T + adults showed significantly faster decline on all outcomes (d = 0.19–0.37). At the last visit prior to death, a greater proportion of A + T + adults (36%) received a dementia diagnosis compared to A − T+ (15%; OR = 6.00), A + T− (14%; OR = 8.00) and A − T− adults (12%; OR = 6.86), <i>p</i> &lt;.001. When analyses were restricted to exclude dementia diagnoses, significantly faster decline on all outcomes (<i>p</i>’s &lt; 0.001, d = 0.29–0.37) was similarly observed in A + T + adults compared to A − T− adults.</p> Conclusions <p>In older adults with concurrent CVD, A + T + at autopsy was associated with greater cognitive decline over 10 years preceding death compared to A − T− older adults. Faster cognitive decline in A + T + in the context of low final visit dementia diagnoses may suggest that <i>post-mortem</i> A + T + is associated with a steep trajectory of cognitive decline <i>ante-mortem</i>, but that dementia progression is not inevitable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ante-mortem cognitive trajectories associated with Aβ and tau biomarker profiles in older adults with cerebrovascular disease: a longitudinal cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月18日

查看全文
  • Emily Rosenich,
  • Yen Ying Lim

摘要

Background

Beta-amyloid (Aβ) plaques and tau tangles are pathological hallmarks of Alzheimer’s disease (AD); however, autopsy studies reveal that most older adults also present with cerebrovascular disease (CVD) markers. It remains unclear how Aβ and tau relate to cognition in the context of concurrent CVD. In initially cognitively unimpaired older adults with CVD, this study aimed to determine ante-mortem cognitive trajectories associated with elevated Aβ and/or tau at autopsy.

Methods

Participants aged 65–95 classified as cognitively unimpaired at baseline from the National Alzheimer’s Coordinating Center database, with ≥ 1 follow-up between 2005 and 2015, and available autopsy/APOE data were included in this cohort study (N = 863). All participants had at least one of six CVD markers at autopsy. Participants were classified into four groups (A − T−, A + T−, A − T+, A + T+) based on semiquantitative Consortium to Establish a Registry for Alzheimer’s Disease neuritic plaque staging and Braak staging. Linear mixed models assessed rate of change in Preclinical Alzheimer’s Cognitive Composite scores, episodic memory, and executive function.

Results

A + T + adults demonstrated significantly faster cognitive decline on all outcomes in the ~ 10 years preceding death compared to A − T− adults (d = 0.34–0.46). Similarly, when compared to A + T − adults, A + T + adults showed significantly faster decline on all outcomes (d = 0.19–0.37). At the last visit prior to death, a greater proportion of A + T + adults (36%) received a dementia diagnosis compared to A − T+ (15%; OR = 6.00), A + T− (14%; OR = 8.00) and A − T− adults (12%; OR = 6.86), p <.001. When analyses were restricted to exclude dementia diagnoses, significantly faster decline on all outcomes (p’s < 0.001, d = 0.29–0.37) was similarly observed in A + T + adults compared to A − T− adults.

Conclusions

In older adults with concurrent CVD, A + T + at autopsy was associated with greater cognitive decline over 10 years preceding death compared to A − T− older adults. Faster cognitive decline in A + T + in the context of low final visit dementia diagnoses may suggest that post-mortem A + T + is associated with a steep trajectory of cognitive decline ante-mortem, but that dementia progression is not inevitable.